Aerocrine AB is a clinically based medical technology corporation dedicated to improved asthma management and care. The company is marketing NIOX® Flex on a worldwide basis and is also marketing NIOX MINO®, representing a new generation of hand-held devices, in Europe. Both products are tailored for rapid, non-invasive control of the inflammatory status in the airways and may play a critical role for a more efficient diagnosis, treatment and monitoring of asthma patients.
Aerocrine is located in Sweden with wholly owned subsidiaries in the US, UK and Germany.
|
|
